This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Allstate (ALL) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Allstate (ALL) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Allstate (ALL) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of 0.73% and 8.51%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks to Watch for Q4 Earnings on Feb 1: MET, AFL & More
by Debasmita Chatterjee
Prudent rate hikes and growing interest rates, partly offset by significant catastrophe losses, are likely to have influenced the fourth-quarter performances of MET, AFL, ALL, AFG and MTG.
Earnings Preview: CNA Financial (CNA) Q4 Earnings Expected to Decline
by Zacks Equity Research
CNA Financial (CNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Invest in the Invesco KBW Property & Casualty Insurance ETF (KBWP)?
by Zacks Equity Research
Sector ETF report for KBWP
Allstate (ALL) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Allstate's (ALL) Q4 results are likely to reflect the impacts of lower net investment income and significant catastrophe losses, partly mitigated by the growing Property-Liability segment's premiums.
Analysts Estimate Allstate (ALL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Allstate (ALL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Do Options Traders Know Something About Allstate (ALL) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Allstate (ALL) stock based on the movements in the options market lately.
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RYF)?
by Zacks Equity Research
Sector ETF report for RYF
Allstate (ALL) Unveils Preliminary Fourth-Quarter Estimates
by Zacks Equity Research
Allstate (ALL) expects its premiums to register year-over-year increase in the fourth quarter of 2022 resulting from continued rate increases. However, catastrophe losses might dampen its underwriting results.
Is Invesco S&P 500 Equal Weight Financials ETF (RYF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYF
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
CECO Environmental and Amazon have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
CECO Environmental and Amazon have been highlighted as Zacks Bull and Bear of the Day.
TRV or ALL: Which P&C Stock is Better-Placed at the Moment?
by Zacks Equity Research
Travelers (TRV) and Allstate (ALL) are poised to grow in the promising P&C insurance space. We try to find out which stock fares better via comparative evaluation.
ProAssurance (PRA) Down 0.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Allstate (ALL) Up 6.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Allstate (ALL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Allstate's (ALL) Premiums Gain From Auto Rate Hikes in October
by Zacks Equity Research
Allstate (ALL) implements auto rate hikes in October to counter inflationary headwinds. Catastrophe losses remain low last month.
Insurance ETFs Rallying on Solid Q3 Earnings
by Sweta Killa
A slew of solid earnings from the leading players in the insurance industry added to the strength as some of the prominent players surpassed estimates for both earnings and revenues.
AXS or ALL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AXS vs. ALL: Which Stock Is the Better Value Option?
Allstate (ALL) Incurs Q3 Loss Due to Weak Underwriting Results
by Zacks Equity Research
Allstate's (ALL) third-quarter results suffer dismal underwriting results and elevated expenses. Its share buyback program is likely to be completed post the first quarter of 2023.
Allstate (ALL) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of 0.64% and 5.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q3 Earnings Due on Nov 2: MET, ALL & LNC
by Kaibalya Pravo Dey
Interest rate hikes and favorable renewals are likely to aid insurers' Q3 results, offset by rising costs and catastrophe losses. MET, ALL and LNC will release earnings on Nov 2.
Can High Catastrophe Losses Hurt Allstate's (ALL) Q3 Earnings?
by Zacks Equity Research
Allstate's (ALL) Q3 results are likely to suffer Hurricane Ian-induced catastrophe losses and inflationary pressures, partly offset by growing premiums within its Property-Liability segment.
Analysts Estimate Allstate (ALL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Allstate (ALL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Everest Re Group (RE) Unveils Q3 Catastrophe Loss Estimates
by Zacks Equity Research
Everest Re's (RE) third-quarter estimated cat loss of $730 million primarily takes into account losses from Hurricane Ian and other global catastrophe events.